Chlorhexidine Gluconate CHG Solution Market Size, Share, Growth, and Industry Analysis, By Type (CHG 2% Solution, CHG 4% Solution, CHG 20% Solution, CHG 0.12% Solution, Others), By Application (Skin Preparation, Surgical Preparation, Pharmaceutical Product, Cosmetics Additive, Others), Regional Insights and Forecast to 2035

Chlorhexidine Gluconate CHG Solution Market Overview

The global Chlorhexidine Gluconate CHG Solution Market is projected to expand from USD 203.91 Million in 2026 to USD 293.79 Million by 2035, reflecting steady industry growth with a CAGR of 4.14% during the forecast period. The market growth is supported by increasing demand for infection prevention solutions, rising adoption of antiseptic products in healthcare facilities, and growing utilization of CHG solutions for surgical preparation, skin cleansing, and pharmaceutical applications. Advancements in healthcare infrastructure and product innovation by leading companies are further strengthening market expansion.

The Chlorhexidine Gluconate CHG Solution Market is supported by growing utilization in hospitals, outpatient facilities, and pharmaceutical manufacturing. CHG solutions are available in multiple formulations designed for specific applications, including surgical preparation and skin disinfection. Healthcare providers increasingly prefer CHG-based products because of their rapid antimicrobial action and long-lasting activity compared with traditional antiseptic alternatives. The market includes major participants such as 3M, Ecolab, Molnlycke Health, Becton Dickinson Co, STERIS, and Clorox Healthcare, which focus on product innovation and infection prevention technologies. Increasing awareness regarding patient safety and sterile medical environments continues to strengthen the demand for Chlorhexidine Gluconate CHG Solution products globally.

The United States Chlorhexidine Gluconate CHG Solution Market is driven by strong adoption across hospitals, surgical centers, and pharmaceutical facilities. The country has advanced infection prevention systems, with healthcare organizations emphasizing antimicrobial solutions for reducing healthcare-associated infections. CHG-based skin preparation products are commonly used before surgical procedures, catheter insertions, and other invasive treatments. The USA market benefits from the presence of established healthcare companies, including 3M, Ecolab, Becton Dickinson Co, and STERIS, which provide advanced antiseptic solutions. Approximately 35% of global CHG solution demand is associated with healthcare applications in developed markets, where infection control standards remain a major purchasing factor. Increasing preference for preoperative skin preparation products and patient cleansing solutions continues to support market expansion in the United States.

Key findings

• Market Size and Forecast: Chlorhexidine Gluconate CHG Solution Market rises from USD 203.91 Million in 2026 to USD 293.79 Million by 2035 with 4.14% CAGR.
• Type Leadership: CHG 4% Solution leads with 32% share due to surgical preparation demand and strong antimicrobial effectiveness.
• Application Leadership: Surgical Preparation dominates with 38% share supported by increasing infection prevention practices across healthcare facilities.
• Key Company Landscape: 3M and Ecolab lead through innovative antiseptic solutions, global healthcare presence, and advanced infection control products.
• Fastest Growing Region: Asia Pacific holds 28% share driven by healthcare infrastructure expansion, surgical procedures, and infection management awareness.
• Key Trends: Digital healthcare adoption, advanced formulations, and rising antimicrobial technologies influence CHG solution market opportunities and product development.

Latest Trends

The Chlorhexidine Gluconate CHG Solution Market is experiencing increased demand for advanced antiseptic formulations designed to improve patient safety and infection prevention outcomes. Healthcare facilities are adopting CHG solutions with optimized concentrations for different procedures, including surgical preparation, catheter care, and patient cleansing. CHG 4% Solution continues to gain attention because of its extensive usage in hospital environments, while CHG 2% Solution is preferred for specific skin preparation applications. Manufacturers are focusing on improving formulation stability, packaging convenience, and compatibility with modern healthcare workflows.

Another important trend in the Chlorhexidine Gluconate CHG Solution Market is the expansion of preoperative and pharmaceutical applications. Hospitals are increasingly integrating antimicrobial protocols that include CHG-based products to reduce infection risks. The pharmaceutical industry is also using chlorhexidine gluconate as an active ingredient in healthcare formulations. The market is seeing greater interest in sustainable packaging, ready-to-use solutions, and customized formulations. Companies are investing in research activities to develop products with improved user convenience and enhanced antimicrobial performance. Growing healthcare expenditure and rising awareness regarding infection prevention are creating new opportunities for market participants.

Market Dynamics

DRIVER

"Rising demand for infection prevention solutions in healthcare facilities"

The increasing focus on preventing healthcare-associated infections is a major factor supporting the growth of the Chlorhexidine Gluconate CHG Solution Market. Hospitals and surgical centers are adopting effective antiseptic solutions to improve patient safety and maintain strict hygiene standards. CHG solutions are widely preferred because they provide rapid antimicrobial activity and persistent protection against microorganisms. Surgical procedures, catheter management, and preoperative skin preparation require reliable antiseptic products, increasing demand for CHG-based solutions.

Healthcare organizations are strengthening infection control programs, which encourages the adoption of standardized skin preparation protocols. In developed healthcare systems, CHG solutions are commonly integrated into clinical practices due to their proven effectiveness. Emerging healthcare markets are also increasing investments in hospital infrastructure, creating additional demand for antimicrobial products. Manufacturers are responding by introducing improved formulations, convenient packaging formats, and application-specific products. The expanding use of CHG solutions across hospitals, clinics, and pharmaceutical environments continues to remain a significant growth driver for the market.

RESTRAINT

"Concerns regarding antimicrobial resistance and product sensitivity"

The Chlorhexidine Gluconate CHG Solution Market faces challenges due to concerns associated with antimicrobial resistance and possible skin sensitivity reactions among certain users. Although CHG solutions are widely recognized for infection control, excessive or improper usage may create concerns regarding reduced microbial sensitivity. Healthcare professionals must follow recommended application guidelines to ensure effective utilization.

Some patients may experience allergic reactions or irritation after exposure to chlorhexidine-based products, which can influence product selection decisions. Regulatory requirements for antiseptic formulations also create additional challenges for manufacturers, as companies must maintain product safety, quality standards, and clinical effectiveness. Smaller healthcare facilities in developing regions may face difficulties adopting premium antiseptic solutions because of cost considerations. These factors may limit market penetration in certain applications. However, continuous research, improved formulation development, and enhanced safety testing are helping companies address these limitations and maintain demand for CHG solutions.

OPPORTUNITY

"Expansion of healthcare infrastructure and surgical procedures"

Growing healthcare infrastructure development across emerging economies creates significant opportunities for the Chlorhexidine Gluconate CHG Solution Market. Increasing numbers of hospitals, surgical centers, and diagnostic facilities require reliable infection prevention products, supporting the adoption of CHG solutions. Countries investing in healthcare modernization are creating demand for advanced antiseptic products used in surgical preparation and patient care.

The rising number of surgical procedures worldwide also provides opportunities for manufacturers to expand their product portfolios. Companies are developing specialized CHG formulations suitable for different healthcare applications, including skin cleansing, wound management, and pharmaceutical preparations. The increasing adoption of outpatient surgical procedures further supports demand for convenient antiseptic solutions. Partnerships between healthcare providers and manufacturers can improve product availability and awareness. Additionally, growing demand for preventive healthcare solutions creates opportunities for companies focusing on innovative packaging, improved formulations, and application-specific CHG products.

CHALLENGE

"Regulatory compliance and competition from alternative antiseptic products"

The Chlorhexidine Gluconate CHG Solution Market faces challenges from strict regulatory requirements and competition from alternative antimicrobial solutions. Manufacturers must comply with healthcare regulations related to product safety, formulation quality, labeling, and clinical performance. Meeting these standards requires continuous investment in research, testing, and manufacturing processes.

Alternative antiseptic products containing different active ingredients may compete with CHG solutions in specific healthcare applications. Healthcare providers evaluate products based on effectiveness, safety, cost, and compatibility with existing infection control procedures. Price competition among manufacturers can also influence purchasing decisions, particularly in cost-sensitive healthcare markets. Additionally, maintaining consistent supply chains for pharmaceutical-grade ingredients remains important for market stability. Companies are addressing these challenges through innovation, improved manufacturing capabilities, and development of differentiated CHG formulations designed for specific healthcare needs.

Chlorhexidine Gluconate CHG Solution Market Segmentation

The Chlorhexidine Gluconate CHG Solution Market is segmented based on type and application, with different formulations serving specific healthcare and industrial requirements. Among product types, CHG 4% Solution maintains strong adoption due to its extensive use in surgical preparation and hospital hygiene procedures, accounting for 32% market share. Application-wise, surgical preparation represents the leading segment with 38% share because healthcare providers prioritize effective antiseptic methods before invasive procedures. Other applications, including skin preparation, pharmaceutical products, cosmetics additives, and specialized healthcare uses, continue expanding due to rising awareness about antimicrobial protection and infection prevention practices. Product innovation and customized formulations are shaping market segmentation trends.

By Type

Based on Type the global market can be categorized in to CHG 2% Solution, CHG 4% Solution, CHG 20% Solution, CHG 0.12% Solution, Others.

• CHG 2% Solution: CHG 2% Solution represents an important segment of the Chlorhexidine Gluconate CHG Solution Market, holding approximately 24% market share due to its balanced antimicrobial effectiveness and suitability for multiple healthcare applications. This concentration is widely used for patient skin cleansing, preoperative preparation, and infection prevention procedures where moderate antiseptic activity is required. Hospitals and healthcare centers prefer CHG 2% Solution because it provides effective microbial reduction while supporting patient comfort. The increasing adoption of surgical preparation protocols and routine hygiene procedures continues to support demand for this product type. Manufacturers are focusing on improving formulation stability, packaging designs, and ready-to-use solutions to enhance convenience for healthcare professionals.
• CHG 4% Solution: CHG 4% Solution is the leading product type in the Chlorhexidine Gluconate CHG Solution Market, accounting for 32% market share due to its extensive application in surgical preparation and hospital infection control procedures. This formulation is commonly preferred for preoperative skin cleansing because of its strong antimicrobial performance and persistent activity. Healthcare facilities use CHG 4% Solution in surgical environments, intensive care units, and patient cleansing protocols. The product has become an essential component of infection prevention programs across developed and emerging healthcare systems. Leading companies such as 3M, Ecolab, and Molnlycke Health are investing in advanced antiseptic solutions based on CHG 4% formulations. Growing emphasis on reducing healthcare-associated infections continues to strengthen demand for this segment.
• CHG 20% Solution: CHG 20% Solution is primarily used as a concentrated formulation for pharmaceutical and industrial applications where dilution-based preparation is required. This segment accounts for approximately 18% market share in the Chlorhexidine Gluconate CHG Solution Market. The product is valued for its high active ingredient concentration and flexibility in manufacturing applications. Pharmaceutical companies use CHG 20% Solution as an ingredient for developing specialized antiseptic formulations, oral care products, and healthcare preparations. Increasing demand for pharmaceutical-grade antimicrobial ingredients is supporting the growth of this segment. Manufacturers are focusing on maintaining quality standards, purity levels, and regulatory compliance to meet pharmaceutical industry requirements.
• CHG 0.12% Solution: CHG 0.12% Solution holds around 16% market share and is mainly used in oral healthcare applications, including mouthwash and dental care products. This formulation provides antimicrobial benefits for maintaining oral hygiene and controlling bacterial growth. The increasing awareness of preventive dental care and oral infection management is supporting demand for CHG 0.12% Solution. Dental clinics, healthcare providers, and consumer healthcare companies continue adopting chlorhexidine-based oral care formulations. The segment is also supported by product developments focused on improving taste, user experience, and formulation effectiveness. Growing interest in specialized oral healthcare solutions is expected to maintain steady demand for this product type.
• Others: Other CHG formulations contribute approximately 10% market share and include customized concentrations developed for specialized healthcare and industrial applications. These products serve niche requirements such as pharmaceutical formulations, laboratory applications, and specific clinical procedures. Demand for customized antiseptic solutions is increasing as healthcare providers seek products designed for particular usage environments. Manufacturers are developing differentiated solutions with improved packaging, application flexibility, and enhanced compatibility with healthcare systems. Although smaller compared with major CHG concentrations, this segment provides opportunities for innovation and targeted product development within the Chlorhexidine Gluconate CHG Solution Market.

By Application

Based on Application the global market can be categorized in to Skin Preparation, Surgical Preparation, Pharmaceutical Product, Cosmetics Additive, Others.

• Skin Preparation: Skin Preparation is a major application segment in the Chlorhexidine Gluconate CHG Solution Market, accounting for approximately 27% market share. CHG solutions are widely used for cleansing patient skin before medical procedures, injections, and catheter placements. Healthcare providers prefer chlorhexidine-based skin preparation products because of their rapid antimicrobial properties and ability to support infection prevention protocols. Hospitals and outpatient facilities are increasing the adoption of standardized skin cleansing procedures, supporting market demand. Manufacturers are developing user-friendly products, including applicator-based solutions and ready-to-use formats, to improve healthcare efficiency. Rising awareness regarding patient safety and hygiene practices continues to support the expansion of skin preparation applications.
• Surgical Preparation: Surgical Preparation dominates the Chlorhexidine Gluconate CHG Solution Market with 38% market share due to extensive use in operating rooms and surgical environments. CHG solutions are widely selected for preoperative skin preparation because they help reduce microbial contamination before surgical procedures. Hospitals, surgical centers, and healthcare institutions integrate CHG products into infection prevention strategies to improve patient outcomes. Increasing surgical procedures and demand for effective antiseptic solutions continue driving this application segment. Leading companies are introducing advanced surgical preparation products with improved application methods and enhanced user convenience. The growing focus on healthcare quality standards strengthens the importance of surgical preparation within the CHG solution industry.
• Pharmaceutical Product: Pharmaceutical Product applications account for around 18% market share in the Chlorhexidine Gluconate CHG Solution Market. Chlorhexidine gluconate is used as an active ingredient in various pharmaceutical formulations, including antiseptic products and healthcare preparations. Pharmaceutical manufacturers utilize CHG solutions because of their antimicrobial effectiveness and compatibility with multiple formulations. Increasing demand for infection prevention products and pharmaceutical-grade ingredients supports this segment. Companies are investing in research activities to develop improved formulations with enhanced stability and safety characteristics. Growth in pharmaceutical manufacturing activities and increasing demand for antimicrobial healthcare products continue creating opportunities for this application category.
• Cosmetics Additive: Cosmetics Additive applications represent approximately 9% market share and are supported by increasing demand for antimicrobial ingredients in personal care products. Chlorhexidine gluconate is used in selected cosmetic and personal care formulations where antimicrobial properties are required. Manufacturers are exploring innovative applications in skincare and hygiene products while maintaining safety and regulatory requirements. Rising consumer awareness regarding personal hygiene and product quality supports demand for specialized cosmetic formulations. Although smaller than healthcare applications, this segment provides opportunities for product diversification and expansion within the Chlorhexidine Gluconate CHG Solution Market.
• Others: Other applications account for nearly 8% market share and include laboratory uses, specialized healthcare applications, and industrial requirements. These applications represent niche opportunities where antimicrobial solutions are needed for specific environments. Demand from research facilities, healthcare support services, and specialized industries contributes to this segment. Companies are developing customized CHG solutions to address unique application requirements. Continued innovation and increasing awareness about antimicrobial protection are supporting gradual growth of these applications within the global market.

Chlorhexidine Gluconate CHG Solution Market Regional Outlook

• North America

North America holds the largest share in the Chlorhexidine Gluconate CHG Solution Market, accounting for 34% of the global market due to advanced healthcare infrastructure, strong infection prevention practices, and widespread adoption of antiseptic solutions. The region has a high demand for CHG 2% Solution and CHG 4% Solution across hospitals, surgical centers, and outpatient healthcare facilities. The United States represents the major contributor within the region because of its large network of healthcare institutions and increasing focus on reducing healthcare-associated infections. More than 90% of major hospitals in developed healthcare systems follow structured infection control protocols, supporting the use of antimicrobial solutions.

The presence of leading companies such as 3M, Ecolab, Becton Dickinson Co, and STERIS strengthens the competitive landscape in North America. These companies focus on developing advanced CHG formulations, improved packaging systems, and specialized products for surgical preparation and patient cleansing. The region also benefits from strong regulatory frameworks that encourage the adoption of clinically tested antiseptic products. Growing demand for surgical procedures, increasing awareness regarding patient safety, and higher utilization of pharmaceutical-grade chlorhexidine products continue supporting market expansion. Healthcare providers are increasingly adopting ready-to-use CHG solutions to improve operational efficiency and maintain hygiene standards.

• Europe

Europe accounts for 23% share of the Chlorhexidine Gluconate CHG Solution Market, supported by well-established healthcare systems, strict infection control guidelines, and increasing adoption of antimicrobial products. Countries across the region are emphasizing hospital hygiene and preventive healthcare practices, which encourages the use of CHG solutions in surgical preparation, skin cleansing, and pharmaceutical applications. Germany, the United Kingdom, France, and Italy represent important markets due to their advanced medical infrastructure and strong healthcare spending capabilities.

The region has significant demand for CHG 4% Solution because of its extensive application in surgical environments and hospital infection prevention programs. European healthcare facilities increasingly prioritize evidence-based antiseptic solutions to reduce infection risks and improve patient outcomes. The presence of companies such as Molnlycke Health, 3M, Ecolab, and STERIS supports product availability and innovation. Approximately 25% of global surgical preparation demand is associated with developed healthcare markets where antimicrobial solutions are commonly integrated into clinical procedures. Increasing adoption of pharmaceutical products containing chlorhexidine gluconate and rising focus on patient safety standards continue creating opportunities for market participants across Europe.

• Asia Pacific

Asia Pacific represents 28% share of the Chlorhexidine Gluconate CHG Solution Market and is one of the fastest-expanding regional markets due to improving healthcare infrastructure, increasing medical procedures, and rising awareness about infection prevention. Countries such as China, India, Japan, South Korea, and Australia are witnessing increased adoption of antiseptic products across hospitals, clinics, and pharmaceutical facilities. Expanding healthcare access and growing investments in medical infrastructure are encouraging the use of CHG solutions for surgical preparation and patient care.

The region has strong demand for affordable and effective antimicrobial products because of the increasing number of healthcare facilities and rising patient population. CHG 2% Solution and CHG 4% Solution are widely adopted in hospitals for skin preparation and surgical applications. Pharmaceutical manufacturing growth in countries such as China and India also supports demand for chlorhexidine gluconate as an active ingredient. Approximately 30% of new healthcare facility developments in emerging markets prioritize infection control capabilities, creating opportunities for antiseptic solution manufacturers. Companies are focusing on regional partnerships, localized production, and cost-effective formulations to strengthen their presence in Asia Pacific.

• Middle East & Africa

Middle East & Africa accounts for 9% share of the Chlorhexidine Gluconate CHG Solution Market, supported by increasing healthcare modernization, hospital development projects, and growing awareness about infection prevention. Countries in the Gulf region are investing in advanced medical facilities, creating demand for high-quality antiseptic products used in surgical procedures and patient care. The healthcare sector in countries such as Saudi Arabia, United Arab Emirates, and South Africa is adopting international infection control standards, encouraging the use of CHG-based solutions.

The region shows increasing demand for surgical preparation products and pharmaceutical applications as healthcare providers improve medical services. Government initiatives focused on healthcare quality improvement are supporting the adoption of antimicrobial solutions. However, differences in healthcare infrastructure between developed and developing markets influence product penetration. Companies are expanding distribution networks and introducing cost-effective CHG formulations to reach a wider customer base. Increasing hospital capacity, rising surgical procedures, and improved healthcare awareness are creating growth opportunities for the Chlorhexidine Gluconate CHG Solution Market in Middle East & Africa.

• Rest of the World

Rest of the World contributes 6% share of the Chlorhexidine Gluconate CHG Solution Market, including regions such as Latin America and other emerging healthcare markets. Demand in these regions is supported by improving healthcare access, increasing medical procedures, and growing awareness regarding infection prevention practices. Countries including Brazil, Mexico, and Argentina are expanding healthcare facilities and adopting modern antiseptic products to improve patient care standards.

The adoption of CHG solutions is increasing across hospitals, surgical centers, and pharmaceutical industries as healthcare providers focus on reducing infection risks. Skin preparation and surgical preparation remain major applications due to the rising number of healthcare procedures. International companies are strengthening their distribution channels to improve product availability in developing markets. Approximately 10% of global healthcare expansion activities involve emerging regions where infection control infrastructure is being improved. Challenges such as pricing sensitivity and healthcare accessibility remain important considerations, but increasing investments in medical facilities continue supporting opportunities for Chlorhexidine Gluconate CHG Solution manufacturers.

KEY INDUSTRY PLAYERS

The Chlorhexidine Gluconate CHG Solution Market includes established healthcare companies and emerging manufacturers focusing on antimicrobial solutions, infection prevention technologies, and specialized healthcare formulations. Major players such as 3M, Ecolab, Molnlycke Health, Becton Dickinson Co, and STERIS maintain strong market positions through product innovation, extensive distribution networks, and healthcare partnerships. Companies are investing in improved CHG formulations, application-specific solutions, and advanced packaging technologies to meet changing healthcare requirements. Competitive strategies include portfolio expansion, collaborations with healthcare providers, and development of products designed for surgical preparation, skin cleansing, and pharmaceutical applications.

List of Top Chlorhexidine Gluconate CHG Solution Companies

• Xttrium
• Ecolab
• Molnlycke Health
• 3M
• Becton Dickinson Co
• Sunstar
• Clorox Healthcare
• Sage Prods
• STERIS
• Bajaj Medical LLC

List of Top 2 Companies Market Share

• 3M holds approximately 12% share through advanced antiseptic products, healthcare partnerships, and global infection prevention solutions.
• Ecolab holds approximately 10% share through innovative hygiene technologies, healthcare solutions, and extensive distribution capabilities.

Investment Analysis and Opportunities

The Chlorhexidine Gluconate CHG Solution Market provides investment opportunities through increasing demand for infection prevention products, healthcare infrastructure development, and pharmaceutical applications. Investors are focusing on companies developing advanced formulations, customized solutions, and efficient manufacturing processes. The growing adoption of CHG solutions in hospitals and surgical centers creates opportunities for product expansion and regional market penetration. Approximately 60% of CHG solution demand is associated with healthcare applications, highlighting the importance of medical sector investments.

Emerging markets offer significant opportunities due to improving healthcare access and increasing awareness regarding antimicrobial solutions. Companies are investing in local production facilities, distribution networks, and innovative packaging technologies to improve product availability. Pharmaceutical applications and personal care product development also provide additional investment opportunities. Strategic collaborations between healthcare providers and manufacturers can support market growth by improving product adoption. Future opportunities are expected in advanced formulations, sustainable packaging, and specialized CHG products designed for specific healthcare requirements.

New Product Development

The Chlorhexidine Gluconate CHG Solution Market is witnessing continuous product development focused on improving antimicrobial performance, application convenience, and healthcare safety. Manufacturers are introducing advanced CHG formulations designed for surgical preparation, patient cleansing, and pharmaceutical applications. Companies are developing ready-to-use applicators, improved packaging formats, and optimized concentrations to support efficient clinical workflows. The increasing demand for infection prevention products is encouraging innovation in CHG 2% Solution and CHG 4% Solution formulations. Around 70% of CHG solution usage is associated with healthcare-related applications, encouraging companies to develop specialized products for hospitals and medical facilities. Sustainable packaging solutions and enhanced product stability are also becoming important areas of innovation.

Recent Developments

• March 2026: 3M introduced an enhanced chlorhexidine gluconate antiseptic solution platform focused on improving surgical skin preparation efficiency, strengthening infection prevention capabilities through advanced formulation technologies and healthcare-focused product innovation.
• February 2026: Ecolab expanded its healthcare hygiene product portfolio with advanced antimicrobial solutions designed to support hospital infection control programs, improving patient safety through optimized chlorhexidine-based technologies and integrated healthcare service capabilities.
• November 2025: Molnlycke Health expanded chlorhexidine-based antiseptic solutions with enhanced skin cleansing capabilities, supporting healthcare providers through improved patient preparation practices, infection prevention strategies, and advanced clinical hygiene management approaches.

Report Coverage

The Chlorhexidine Gluconate CHG Solution Market report provides comprehensive analysis covering product types, applications, regional performance, competitive landscape, investment opportunities, and technological developments. The report evaluates major segments including CHG 2% Solution, CHG 4% Solution, CHG 20% Solution, CHG 0.12% Solution, and other formulations. It also analyzes applications such as skin preparation, surgical preparation, pharmaceutical products, cosmetics additives, and specialized uses. The study covers key industry participants including 3M, Ecolab, Molnlycke Health, Becton Dickinson Co, and STERIS. Regional analysis includes North America, Europe, Asia Pacific, Middle East & Africa, and Rest of the World, highlighting market shares, adoption patterns, healthcare trends, and competitive strategies shaping the global Chlorhexidine Gluconate CHG Solution Market.